Terms: = Prostate cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Staging
4 results:
1. Human papilloma virus (HPV) integration signature in Cervical cancer: identification of MACROD2 gene as HPV hot spot integration site.
Kamal M; Lameiras S; Deloger M; Morel A; Vacher S; Lecerf C; Dupain C; Jeannot E; Girard E; Baulande S; Dubot C; Kenter G; Jordanova ES; Berns EMJJ; Bataillon G; Popovic M; Rouzier R; Cacheux W; Le Tourneau C; Nicolas A; Servant N; Scholl SM; Bièche I;
Br J Cancer; 2021 Feb; 124(4):777-785. PubMed ID: 33191407
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of prostatic adenocarcinoma Gleason 5 and intraductal carcinoma of the prostate with tumor necrosis. A morphometric study.
Acosta AM; Vormittag E; Al Rasheed MRH; Sharif A; Mon KS; Kajdacsy-Balla A; Mohapatra G
Pathol Res Pract; 2018 Oct; 214(10):1681-1685. PubMed ID: 30195638
[TBL] [Abstract] [Full Text] [Related]
3. Utility of p63 immunohistochemical stain in differentiating urothelial carcinomas from adenocarcinomas of prostate.
Ud Din N; Qureshi A; Mansoor S
Indian J Pathol Microbiol; 2011; 54(1):59-62. PubMed ID: 21393879
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic utility of P504S/p63 cocktail, prostate-specific antigen, and prostatic acid phosphatase in verifying prostatic carcinoma involvement in seminal vesicles: a study of 57 cases of radical prostatectomy specimens of pathologic stage pT3b.
Harvey AM; Grice B; Hamilton C; Truong LD; Ro JY; Ayala AG; Zhai QJ
Arch Pathol Lab Med; 2010 Jul; 134(7):983-8. PubMed ID: 20586625
[TBL] [Abstract] [Full Text] [Related]
